Follicular Lymphoma

$Spotlight on Relapsed/Refractory Follicular Lymphoma$	Spotlight on Relapsed/Refractory Follicular Lymphoma CME, CPE James O. Armitage, MD; and Reid W. Merryman, MD
	Release Date: December 09, 2022 Expiration Date: December 09, 2023
	In this activity, Dr. Merryman will address the expanding landscape in the treatment of follicular lymphoma and, along with Dr. Armitage, they will discuss the current standard of care. Dr. Merryman will provide a comprehensive overview of the emerging data in the relapsed setting and discuss the current placement of those agents in the future treatment paradigm with a discussion of potential impact to patient care and outcomes. Provided by MediCom Worldwide, Inc. This activity is supported by an educational grant from Genentech, a member of the Roche Group.
	Begin, Earn Credit View Only, No Credit

	Current and Emerging Directions in the Frontline Treatment of Follicular Lymphoma: Implications for Practice CME, CPE James O. Armitage, MD; and Gilles Salles, MD, PhD
	Release Date: October 19, 2022 Expiration Date: October 19, 2023
	In this activity, Dr. Salles will address current and emerging directions in the frontline treatment of follicular lymphoma, he will also discuss recent evidence on emerging therapies and describe implications for current and future practice. To conclude, Dr. Armitage and Dr. Salles examine how to apply these therapies to practice and how to individualize therapy for patients. Provided by MediCom Worldwide, Inc. This activity is supported by an educational grant from Genentech, a member of the Roche Group.
	Begin, Earn Credit View Only, No Credit